How much does JEVTANA cost?

How much does JEVTANA cost?

The cost for Jevtana intravenous solution (60 mg/1.5 mL) is around $12,669 for a supply of 1.5 milliliters, depending on the pharmacy you visit.

Is cabazitaxel stronger than docetaxel?

Cabazitaxel at two different doses was no better than docetaxel with regard to OS or PFS in men with metastatic castration-resistant prostate cancer.

Is JEVTANA covered by Medicare?

Medicare covers JEVTANA under the Medicare Part B benefit. In most cases, JEVTANA claims will be processed by Part A/B Medicare Administrative Contractors (MACs) (for physician office and hospital sites of service), Carriers (physician office) or Fiscal Intermediaries (hospitals).

Is JEVTANA a chemotherapy?

Jevtana (cabazitaxel) is classified as a taxane chemotherapy drug and a microtubule inhibitor. The course of action of these types of treatments is based on stopping the cancerous cells from diving into new cells, which then blocks the growth of the cancer.

Is chemo a last resort?

“Cancer chemotherapy has evolved from a last resort 60 years ago to treatment that now can cure patients or markedly prolong their lives, often with far fewer side effects than with the original drugs decades ago,” says Joseph Paul Eder, MD, a Yale Medicine medical oncologist.

How often is JEVTANA given?

Dosing Information The recommended dose of JEVTANA is based on calculation of the Body Surface Area (BSA), and is 20 mg/m2 administered as a one-hour intravenous infusion every three weeks in combination with oral prednisone 10 mg administered daily throughout JEVTANA treatment.

How long is cabazitaxel effective?

Treatment with cabazitaxel The median duration of cabazitaxel treatment was 3.4 months with a median of five cycles. Among patients who had discontinued cabazitaxel at 18 months (95%), the main reasons for discontinuation were disease progression or disease-related death (83.2%), or the occurrence of AEs (15.2%).

What is the difference between docetaxel and cabazitaxel?

In the first-line treatment of metastatic castration-resistant prostate cancer, there was no difference in overall survival observed for cabazitaxel vs docetaxel regimens. However, toxicity profiles differed, with lower-dose cabazitaxel being associated with less toxicity overall.

Does Medicare cover J codes?

J-codes are reimbursement codes used by commercial insurance plans, Medicare, Medicare Advantage, and other government payers for Medicare Part B drugs like Jelmyto that are administered by a physician.

Does JEVTANA cause hair loss?

Temporary hair loss may occur. Normal hair growth should return after treatment has ended. Many people using this medication develop serious side effects. However, your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects.